Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") today announced that Philip Johnson has been appointed Executive Vice...

Related Keywords

Ireland ,Indianapolis ,Indiana ,United States ,Dublin ,Kristin Bhavnani ,Philip Johnson ,Phil Johnson ,Eli Lilly ,Andrean Flynn ,Bruce Cozadd ,University Of Illinois ,Indiana Chamber ,Lilly Group Vice ,Prnewswire Jazz Pharmaceuticals ,Group Vice ,Action Fund ,Indianapolis Urban League ,Jazz Pharmaceuticals ,Kellogg School Of Management At Northwestern University ,Leadership Team ,Nasdaq ,Mckinsey Company ,Advisory Committee ,Johnson Brings Over ,Operating Experience ,Executive Vice President ,Chief Financial Officer ,Chief Operating Officer ,Group Vice President ,Chief Executive Officer ,Senior Vice President ,Investor Relations ,Indianapolis Urban ,Lynx Capital ,Jumpstart Nova ,Kellogg School ,Strategic Brand ,Jazz Pharmaceuticals Plc ,Pharmaceuticals ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,Personnel Announcements ,